Atlas Trials

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

Clinical trial NCT05391022 · COMPLETED

Trial details

NCT number
NCT05391022
Sponsor
Constellation Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced MalignanciesSolid TumorHematological Malignancy
Start date
2021-07-20
Primary completion
2023-03-08
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.